1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Multi-drug Resistant Tuberculosis: new trials by email Literature Review of Multi-drug Resistant Tuberculosis trials Research Report on Multi-drug Resistant Tuberculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis Arm A Double-blind Phase: TMC207, Arm B Double-blind Phase: Placebo, Treatment Failure During Double-blind Phase: TMC207 - Multi-drug Resistant Tuberculosis | Phase 3 | Withdrawn | Janssen Infectious Diseases BVBA | 2014-03-01 | 2015-12-02 |
Tuberculosis, Multidrug-Resistant (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Mycobacterium Infections (1) · Tuberculosis (1)
Janssen Infectious Diseases BVBA (1)
Brazil (1) · Cambodia (1) · China (1) · Estonia (1) · Ethiopia (1) · Georgia (1) · Latvia (1) · Mexico (1) · Peru (1) · Philippines (1) · Russia (1) · South Africa (1) · South Korea (1) · Taiwan (1) · Thailand (1)